How to Win the Biosimilars Race in the European Union Onco-Therapeutics Market in 2020?

Market Research

The healthcare market has been growing for biosimilars in the European Union (EU), however, the rosy picture is expected to change as the long term sustainability of the pharmaceutical market is expected to come under lens due to shortage of big biologic patent expiries.

The entry of Chinese and Singaporean drug manufacturers causes a slight change of focus to the Russian and Central Europe region and also because of a growing number of new innovative drugs targeted at focused patient groups. 

Download this Whitepaper, based on a study conducted by SG Analytics to know more.

To know more...


Related Topics

SG Analytics - Healthcare - Whitepaper - Emergence of Novel Immune-Mediated Therapies


Emergence of Novel Immune - Mediated Therapies

Immunotherapy has emerged as a promising treatment for cancer, with immune checkpoint inhibitors (ICIs) dominating the market. The market is projected to...

Technological  Advancements


Future Trends and Technological Advances in Vaccine...

The introduction of vaccines for key diseases, such as meningococcal meningitis A, hepatitis E, and malaria, in recent years has helped to reduce mortality...

Trends to Watch 2024 - Media Broadcast Tech


2024 Trends to Watch -TV & Video Technology

Media enterprises are steadily witnessing margin pressures attributed to the emergence of newer audience engagement touchpoints such as FAST channels,...

We bring comprehensive data driven insights to everyone, everywhere